BI
VC

BioAdvance

United Statesbioadvance.com

BioAdvance is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Personalized Medicine and Pharmaceutical Development, 7 tracked investments.

7
Investments Tracked

About BioAdvance

BioAdvance is a venture capital firm headquartered in the United States. We have recorded 7 investments for BioAdvance to date.

Sector activity concentrates in Healthcare & Life Sciences, Personalized Medicine, Pharmaceutical Development and Oncology & Cancer Treatment. Coverage extends to 8 sectors in total. Participation spans Seed, Series A and Series B rounds.

BioAdvance invests in early-stage healthcare and life science companies. They focus on companies in the US.

Investment Focus

Stage Focus
seedseries-aseries-b
Sectors
Healthcare & Life SciencesPersonalized Medicinepharmaceutical-developmentOncology & Cancer TreatmentHealthcare Techhospital careneurodegenerationnutrition management

Investment Thesis

BioAdvance invests in early-stage healthcare and life science companies. They focus on companies in the US.

BioAdvance Portfolio Companies

8 tracked holdings.

Portfolio outcomes
9 active1 stalled

Team

Shahram HejaziManaging Director & CEO

Life science investor and entrepreneur with general management experience. Focus on research tools, devices, diagnostics and digital health. PhD in electrical engineering with emphasis in biophysics.

Gregory HarrimanPartner

Accomplished physician, scientist and biomedical executive with over 25 years experience in academic medicine and biopharmaceutical industry. Led clinical R&D groups for drugs and biologics including Remicade.

David ShinPartner

Trained physician and engineer with over 20 years of investment management and executive operating experience. Deep focus in therapeutics and software development for life sciences.

Rick JonesAdvisory Partner

Over 30 years in life science industries serving as physician, executive, consultant, director and investor. Responsible for investments in therapeutics and medical devices.

Robert DriscollDirector of Finance

Twenty years of finance expertise in multi-national corporations and venture-backed life sciences firms. Focus on financial management, reporting, consolidation, and internal controls.

Marnie McCoyProgram Director

Responsible for maintaining organizational outreach to applicants and internal facilitation of funding application and review process. Completed Rutgers University Mini-MBA program in 2015.

Gayle MineoOffice Management

More than 15 years of experience in management and business development in life sciences sector. Provides operational support and high-level administration services for C-Suite.

Barbara SchilbergAdvisor & Former CEO

More than 30 years working with academic technologies and start-ups in life sciences. CEO 2002-2021, committed over $50 million to almost 100 seed-stage companies.

Jeff EdelsonEntrepreneur-in-Residence

Pulmonologist with over 30 years of clinical practice, research and management experience. Served as EIR/Scientific Liaison since May 2008. Principal of AEQuanimitas Consulting LLC.

Explore BioAdvance's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Personalized Medicine